Summary Information:
Apyx Medical Corporation Common Stock
NASDAQ:APYX


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Apyx Medical Corporation Common Stock
Exchange: NASDAQ
Symbol: APYX
SEC CIK: 0000719135
Phone: 7273842323
5115 ULMERTON ROAD
CLEARWATER FL 33760

CEO: Charles Goodwin
Price when page updated: 2.74 Date: 2023-11-30
Company Website:
apyxmedical.com

_Description: Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

IPO YEAR:

Sector:
Health Care
Industry:
Medical/Dental Instruments
ADRTSO:

MarketCap:
94924163.00
Beta:
1.57630571928247
52 Week High:
17.5
52 Week Low:
6.71
52 Week Change:
0.862215909090909
Short Interest:

Short Date:

Shares Outstanding:
34343750
Dividend Rate:
0
Dividend Yield:
0.00%
ExDividend Date:

Latest EPS:

Latest EPS Date:
14 Nov 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
$423.264M
Gross Profit:

Cash:

Debt:

Institution Percent:
48.50%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.70%
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
2.74
Short Ratio:
3.96
PE Ratio:
0
Employees:
0
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Apyx Medical Corporation Common Stock [ APYX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30